ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

147
Analysis
Health CareUnited States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
01 Oct 2016 19:32

2016 US Elections Scenario Two: Donald Trump Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
219 Views
Share
01 Oct 2016 19:29

2016 US Elections Scenario One: Hillary Clinton Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
206 Views
Share
01 Oct 2016 19:07

On Trade, An Era Is Ending

Whatever the outcome of the US election, President Barack Obama's departure in early 2017 will present renewed challenges for Asia Pacific trade....

Logo
222 Views
Share
12 Sep 2016 22:34

US Stock Market Seasonality:  Shemitah Redux, The Afterparty

Almost exactly a year ago I wrote a piece on stock market seasonality titled Stock Market Seasonality - Januaries, SuperBowls, Third Years,...

Logo
227 Views
Share
05 Sep 2016 08:03

ANIMAL SPIRITS REPORT 2: APAC Valuation and Earnings Snapshot

Asia Pacific Investment Strategy  In this series of introductory notes, Animal Spirits outlines the investment process and analytical framework we...

Share
x